A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
Authors:
Open Access
- 21 October 2021
- journal article
- research article
- Published by Elsevier in Stem Cell Reports
- Vol. 16 (11) , 2825-2837
Abstract
No abstract availableKeywords
All Related Versions
This publication has 61 references indexed in Scilit:
- Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cellsProceedings of the National Academy of Sciences, 2014
- Efficient generation of lung and airway epithelial cells from human pluripotent stem cellsNature Biotechnology, 2013
- A functional CFTR assay using primary cystic fibrosis intestinal organoidsNature Medicine, 2013
- Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR proteinNature Biotechnology, 2012
- CFTR: folding, misfolding and correcting the ΔF508 conformational defectTrends in Molecular Medicine, 2012
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809Proceedings of the National Academy of Sciences, 2011
- Assay Data Quality Assessment2009
- A pair of new statistical parameters for quality control in RNA interference high-throughput screening assaysGenomics, 2007
- Alteration of the Cystic Fibrosis Transmembrane Conductance Regulator Folding PathwayJournal of Biological Chemistry, 1996
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisCell, 1990